Roche seeks partner to take over plant, produce key antibiotic
After manufacturing the antibiotic Rocephin for four decades—and developing it into one of the company’s first blockbuster medicines—Roche…
Basilea lands US$6m CARB X boost for novel antibiotic
The money is non‑dilutive and follows the successful completion of investigational‑new‑drug‑enabling work and the project’s green‑light for clinical…
![[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong 2025 results with 7% sales growth](https://www.europesays.com/ch/wp-content/uploads/2026/02/84b0110bbf60eb8397db0461bc3549c4-380x220.png)
Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry’s broadest in vitro diagnostic menu
F. Hoffmann-La Roche Ltd With this approval, Roche’s automated mass spectrometry platform now offers the industry’s broadest in…